California Wrongful Death Suit Links Arterial Disease to Novartis Cancer Drug
March 30, 2016
FRESNO, Calif. — The family of a California man who died from an atherosclerosis-related condition allegedly caused by the leukemia drug Tasigna has sued Novartis AG, claiming the manufacturer failed to warn doctors and patients in the United States about dangerous side effects linked to the drug.
In a March 22 complaint filed in U.S. District Court for the Eastern District of California, the surviving family of Dainis Lauris contend that since at least 2011, Novartis has been aware of numerous reports indicating that Tasigna caused severe, accelerated and irreversible atherosclerosis in patients taking the drug. However, Novartis never disclosed …
- Elias Gutzler Spicer
- Weakley & Arendt